Results 51 to 60 of about 54,639 (294)

Wiskott–Aldrich syndrome that was initially diagnosed as immune thrombocytopenic purpura secondary to a cytomegalovirus infection

open access: yesSAGE Open Medical Case Reports, 2018
Wiskott–Aldrich syndrome is a rare X-linked recessive disease resulting from variations in the WAS gene. Wiskott–Aldrich syndrome is sometimes difficult to differentiate from immune thrombocytopenic purpura. A 2-month-old boy was admitted to our hospital
Ryota Kaneko   +8 more
doaj   +1 more source

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. [PDF]

open access: yes, 2008
Idiopathic thrombocytopenic purpura (ITP) is characterized by a low platelet count, which is the result of both increased pla- telet destruction and insufficient platelet production.
Amadori, S   +5 more
core   +1 more source

Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

open access: yesBleeding, Thrombosis and Vascular Biology
Immune thrombocytopenia (ITP) is an autoimmune disease that causes a drop in platelet count
Giuseppe Auteri   +3 more
doaj   +1 more source

A clinical case of thrombocytopenic purpura in a 13-year-old child

open access: yesЛечащий Врач
Background. Immune thrombocytopenic purpura is an immune-mediated disease that develops as a result of impaired immune tolerance to platelet antigens and the formation of antibodies to them, followed by a decrease in platelet levels per unit volume of ...
A. Yu. Babko   +2 more
doaj   +1 more source

FIGO guideline on liver disease and pregnancy

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 1, Page 28-48, July 2025.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana   +24 more
wiley   +1 more source

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal [PDF]

open access: yes, 2008
Evidence Review Group (ERG) final report for the National Institute for Health and Clinical ExcellencePublisher ...
Boyers, Dwayne   +5 more
core  

Utility and Safety of Romiplostim as an Alternative to Platelet Transfusion for Neonates

open access: yesPediatric Blood &Cancer, Volume 72, Issue 7, July 2025.
ABSTRACT Thrombocytopenia is a common challenge in the neonatal intensive care unit, traditionally managed with platelet transfusions. However, transfusions are associated with significant risks, including increased mortality and neurodevelopmental impairment.
Rachel N. Zeno, Sara Awad, Harry Lesmana
wiley   +1 more source

Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

open access: yesNature Communications, 2022
Here, Simpson et al. analyze data from 3.6 million COVID-19 vaccine second doses (ChAdOx1 and BNT162b2) in Scotland for risk of thrombocytopenic, thromboembolic and hemorrhagic events.
Colin R. Simpson   +14 more
doaj   +1 more source

A Red Skin in the Setting of Chickenpox: A Rare Report of Eosin Toxicity

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Eosin Yellowish (Eosin‐Y) is an effective treatment option for a range of dermatological conditions. It is crucial to carefully identify patients presenting systemic adverse reactions related to topical aqueous Eosin‐Y overuse and to monitor them closely during short‐term use to prevent severe complications.
Bahareh Abtahi‐Naeini   +5 more
wiley   +1 more source

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.

open access: yesBlood, 2018
Preemptive rituximab infusions prevent relapses in immune thrombotic thrombocytopenic purpura (iTTP) by maintaining normal ADAMTS13 activity. However, the long-term outcome of these patients and the potential adverse events of this strategy need to be ...
M. Jestin   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy